These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20145354)

  • 1. Effects of raloxifene on brachial arterial endothelial function, carotid wall thickness, and arterial stiffness in osteoporotic postmenopausal women.
    Sumino H; Ichikawa S; Kasama S; Takahashi T; Sakamoto H; Koizumi A; Kanai H; Araki Y; Itoh T; Iwasaki T; Sawada Y; Saito Y; Kumakura H; Takayama Y; Kanda T; Murakami M; Sakamaki T; Kurabayashi M
    Int Heart J; 2010 Jan; 51(1):60-7. PubMed ID: 20145354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women.
    Saitta A; Altavilla D; Cucinotta D; Morabito N; Frisina N; Corrado F; D'Anna R; Lasco A; Squadrito G; Gaudio A; Cancellieri F; Arcoraci V; Squadrito F
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1512-9. PubMed ID: 11557681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raloxifene improves the ovariectomy-induced impairment in endothelium-dependent vasodilation.
    Takahashi K; Mori-Abe A; Takata K; Ohta T; Kawagoe J; Tsutsumi S; Ohmichi M; Kurachi H
    Menopause; 2007; 14(4):656-61. PubMed ID: 17242632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of raloxifene on endothelium-dependent dilation, lipoproteins, and markers of vascular function in postmenopausal women with coronary artery disease.
    Griffiths KA; Sader MA; Skilton MR; Harmer JA; Celermajer DS
    J Am Coll Cardiol; 2003 Aug; 42(4):698-704. PubMed ID: 12932604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carotid artery intima-media thickness after raloxifene treatment.
    Mack WJ; Dhungana B; Dowsett SA; Keech CA; Feng M; Li Y; Hodis HN
    J Womens Health (Larchmt); 2007 Apr; 16(3):370-8. PubMed ID: 17439382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverse correlation of carotid intima-media thickness with raloxifene serum levels in osteoporosis.
    Lušin TT; Mrhar A; Marc J; Trontelj J; Zavratnik A; Zegura B; Pfeifer M; Ostanek B
    Wien Klin Wochenschr; 2014 Jul; 126(13-14):403-8. PubMed ID: 24842749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of combined use of three non-invasive atherosclerosis tests to predict vascular events in the elderly; carotid intima-media thickness, flow-mediated dilation of brachial artery and pulse wave velocity.
    Nagai K; Shibata S; Akishita M; Sudoh N; Obara T; Toba K; Kozaki K
    Atherosclerosis; 2013 Dec; 231(2):365-70. PubMed ID: 24267253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pitavastatin calcium improves endothelial function and delays the progress of atherosclerosis in patients with hypercholesterolemia.
    Zhao J; Yan HM; Li Y; Wang J; Han L; Wang ZH; Tang MX; Zhang W; Zhang Y; Zhong M
    J Zhejiang Univ Sci B; 2015 May; 16(5):380-7. PubMed ID: 25990055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative vascular effects of hormone replacement therapy and raloxifene in women at increased cardiovascular risk.
    Cerquetani E; Vitale C; Mercuro G; Fini M; Zoncu S; Rosano GM
    Gynecol Endocrinol; 2004 Jun; 18(6):291-8. PubMed ID: 15497491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arterial pulse wave velocity in relation to carotid intima-media thickness, brachial flow-mediated dilation and carotid artery distensibility: the Cardiovascular Risk in Young Finns Study and the Health 2000 Survey.
    Koivistoinen T; Virtanen M; Hutri-Kähönen N; Lehtimäki T; Jula A; Juonala M; Moilanen L; Aatola H; Hyttinen J; Viikari JS; Raitakari OT; Kähönen M
    Atherosclerosis; 2012 Feb; 220(2):387-93. PubMed ID: 21871623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjugated equine estrogen, raloxifene and arterial stiffness in postmenopausal women.
    Dias AR; de Mello NR; Eluf Gebara OC; Nussbacher A; Wajngarten M; Petti DA
    Climacteric; 2008 Oct; 11(5):390-6. PubMed ID: 18781483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrelationship between non-invasive measurements of atherosclerosis: flow-mediated dilation of brachial artery, carotid intima-media thickness and pulse wave velocity.
    Kobayashi K; Akishita M; Yu W; Hashimoto M; Ohni M; Toba K
    Atherosclerosis; 2004 Mar; 173(1):13-8. PubMed ID: 15177119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose atorvastatin in peripheral arterial disease (PAD): effect on endothelial function, intima-media-thickness and local progression of PAD. An open randomized controlled pilot trial.
    Spring S; Simon R; van der Loo B; Kovacevic T; Brockes C; Rousson V; Amann-Vesti B; Koppensteiner R
    Thromb Haemost; 2008 Jan; 99(1):182-9. PubMed ID: 18217152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrahydrobiopterin improves endothelial function and decreases arterial stiffness in estrogen-deficient postmenopausal women.
    Moreau KL; Meditz A; Deane KD; Kohrt WM
    Am J Physiol Heart Circ Physiol; 2012 Mar; 302(5):H1211-8. PubMed ID: 22245769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raloxifene does not influence flow-mediated endothelium-dependent and endothelium-independent vasodilatation of osteopenic postmenopausal women.
    Cagnacci A; Arangino S; Renzi A; Zanni AL; Volpe A
    Am J Obstet Gynecol; 2003 Feb; 188(2):313-7. PubMed ID: 12592232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between brachial arterial endothelial function and lumbar spine bone mineral density in postmenopausal women.
    Sumino H; Ichikawa S; Kasama S; Takahashi T; Sakamoto H; Kumakura H; Takayama Y; Kanda T; Murakami M; Kurabayashi M
    Circ J; 2007 Oct; 71(10):1555-9. PubMed ID: 17895551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raloxifene, conjugated oestrogen and endothelial function in postmenopausal women.
    Duschek EJ; Stehouwer CD; de Valk-de Roo GW; Schalkwijk CG; Lambert J; Netelenbos C
    J Intern Med; 2003 Jul; 254(1):85-94. PubMed ID: 12823645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raloxifene and endothelial function in healthy postmenopausal women.
    Sarrel PM; Nawaz H; Chan W; Fuchs M; Katz DL
    Am J Obstet Gynecol; 2003 Feb; 188(2):304-9. PubMed ID: 12592230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of raloxifene on carotid blood flow resistance and endothelium-dependent vasodilation in postmenopausal women.
    Ceresini G; Marchini L; Rebecchi I; Morganti S; Bertone L; Montanari I; Bacchi-Modena A; Sgarabotto M; Baldini M; Denti L; Ablondi F; Ceda GP; Valenti G
    Atherosclerosis; 2003 Mar; 167(1):121-7. PubMed ID: 12618276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the selective estrogen receptor modulator, raloxifene, on carotid artery pulsatility index in postmenopausal women.
    Setacci C; la Marca A; Agricola E; Morgante G; Setacci F; Cappelli A; Petraglia F; De Leo V
    Am J Obstet Gynecol; 2002 Apr; 186(4):832-5. PubMed ID: 11967516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.